Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FAE.MCthis companyFaes Farma, S.A.	€4.92	19.85×	2.16×	2.63×	18.65×	-29.6%	37.4%	11.9%	13.0%	10.7%	5.7%	3.9%	0.55×	2.87×	11.51×	2.61×	3.5%	5	2.82	4	A
ALM.MCAlmirall, S.A.	€10.50	58.36×	1.85×	2.49×	12.62×	30.9%	41.2%	6.1%	4.2%	3.1%	2.1%	4.9%	0.23×	0.02×	3.79×	2.04×	0.9%	7	2.93	3	B+
ATRY.MCAtrys Health, S.A.	€2.60	-2.22×	1.47×	1.58×	-46.9×	-255.2%	43.5%	-6.4%	-71.1%	-66.0%	-2.1%	-6.3%	1.7×	-24.57×	-0.47×	0.81×	0.0%	3	-0.45	1	C-
BST.MCBiotechnologies Assets S.A.	€0.21	-7.42×	2.31×	4.61×	138.37×	-110.4%	-16.6%	-61.6%	-62.0%	-31.0%	-16.8%	-0.1%	0.28×	11.74×	-11.17×	1.4×	0.0%	4	-1.34	1	C-
GRF.MCGrifols, S.A.	€11.38	18.45×	1.4×	0.98×	9.55×	244.9%	35.7%	16.4%	5.3%	7.6%	5.5%	8.5%	1.81×	5.18×	1.98×	2.51×	1.7%	7	1.12	3	B-
ORY.MCOryzon Genomics S.A.	€2.38	-88.86×	2.19×	0×	-34.19×	-90.8%	0.0%	0.0%	0.0%	-2.5%	-2.2%	-1.0%	0.11×	2.61×	-10.55×	1.95×	0.0%	2	5.2	2	C+
Peer median	—	-2.22×	1.85×	1.58×	9.55×	-90.8%	35.7%	0.0%	0.0%	-2.5%	-2.1%	-0.1%	0.28×	2.61×	-0.47×	1.95×	0.0%	4	1.12	2	—